Secondary forms of metabolic dysfunction-associated steatotic liver disease (MASLD) have different pathogeneses, ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the population in many developed countries. 1 The disease ranges from steatosis to non-alcoholic steatohepatitis ...

High BMI (⩾25 kg/m 2) and steatosis on both liver histology and US (>24% of fatty liver cells) were associated with reduced interobserver ICC (table 2). Low or absent histological stages for hepatic ...

Waist-to-height ratio (WHtR) outperforms body mass index (BMI) in detecting the risk for liver disease, according to a study ...

Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If ...

Waist-to-height ratio had a better predictive value than BMI in assessing liver fibrosis and steatosis outcomes across ages and racial groups.

Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If ...

There was no association observed between lower income and increased fibrosis among New York City residents with metabolic dysfunction-associated steatohepatitis (MASH).

It provides a numerical quantitative estimate of liver steatosis ranging from 0.00 to 1.00, ... France, 5 Department of Pathology, Hôpital Antoine Béclère, Clamart, France, 6 Department of ...